EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CDK1 Phosphorylates KAT8 at Ser348 to Stabilize the MSL Complex and Promote H4K16 Acetylation in Non-Small Cell Lung Cancer

Jinmeng Chu, Qingzhi Zhao, Hui Ye, Meixu Li, Yizhen Wang, Tiantian Xu, Yong Cai, Jingji Jin iD

Cells · 2026

DOI: 10.3390/cells15100897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Jinmeng Chu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Jilin University, Changchun 130012, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, CDC2 Protein Kinase, Histones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclin-dependent kinase 1 (CDK1) is frequently upregulated in multiple cancers and plays a central role in cell cycle progression and tumorigenesis. However, whether CDK1 directly regulates the histone acetyltransferase KAT8 (also known as MOF) in non-small cell lung cancer (NSCLC) remains unclear. Here, we identify CDK1 as a kinase that directly interacts with and phosphorylates KAT8 at serine 348 (S348) and threonine 418 (T418). Mechanistically, CDK1-mediated phosphorylation, particularly at S348, enhances the interaction between KAT8 and MSL1, thereby stabilizing the MSL complex and promoting KAT8-dependent acetylation of histone H4 at lysine 16 (H4K16). Functionally, the phosphorylation-deficient mutant KAT8-S348A exhibits impaired MSL complex assembly, reduced H4K16 acetylation, and decreased NSCLC cell proliferation both in vitro and in vivo. Pharmacological inhibition of CDK1 using RO-3306 suppresses KAT8 phosphorylation and H4K16 acetylation, leading to significant tumor growth inhibition. Notably, this effect is partially rescued by re-expression of wild-type KAT8 but not by the S348A mutant, supporting a phosphorylation-dependent mechanism. Collectively, these findings define a CDK1–KAT8 signaling axis that promotes NSCLC proliferation through epigenetic regulation and suggest that targeting CDK1-dependent KAT8 phosphorylation may represent a potential therapeutic strategy for lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsCDC2 Protein KinaseHistonesHistone AcetyltransferasesHumansPhosphorylationAcetylationAnimalsCell Line, TumorCell ProliferationSerineLysineMice, Nude

Stichwörter der Autor:innen

CDK1KAT8cell proliferationdrug-resistancenon-small cell lung cancerphosphorylation

Substanzen

CDC2 Protein KinaseHistonesKAT8 protein, humanHistone AcetyltransferasesCDK1 protein, humanSerineLysine

Autor:innen und Institutionen

  • School of Life Sciences, Jilin University, Changchun 130012, China.

ORCID-Profile: Jingji Jin

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chu, J., Zhao, Q., Ye, H., Li, M., Wang, Y., Xu, T., Cai, Y., & Jin, J. (2026). CDK1 Phosphorylates KAT8 at Ser348 to Stabilize the MSL Complex and Promote H4K16 Acetylation in Non-Small Cell Lung Cancer. Cells. https://doi.org/10.3390/cells15100897

Vancouver

Chu J, Zhao Q, Ye H, Li M, Wang Y, Xu T, et al. CDK1 Phosphorylates KAT8 at Ser348 to Stabilize the MSL Complex and Promote H4K16 Acetylation in Non-Small Cell Lung Cancer. Cells. 2026. doi:10.3390/cells15100897

BibTeX
@article{Chu2026,
  author = {Chu, Jinmeng and Zhao, Qingzhi and Ye, Hui and Li, Meixu and Wang, Yizhen and Xu, Tiantian and Cai, Yong and Jin, Jingji},
  title = {CDK1 Phosphorylates KAT8 at Ser348 to Stabilize the MSL Complex and Promote H4K16 Acetylation in Non-Small Cell Lung Cancer},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15100897}
}
Kostenlos starten →